Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The wirehouse’s independent channel has become the fastest growing segment of its wealth management unit and helped retain advisors.
The index investors consider as a basket of blue chip stocks has taken a hard turn toward growth, and away from mature dividend stocks.
The past two years haven’t been too kind to Wall Street comp plans, but that might be changing as bonuses make a comeback.